Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Running, not enrolling · Phase 3 · Has a placebo group
Conditions studied: Overweight, Obesity, Type 2 Diabetes
In brief
This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilintide is a new investigational medicine. Doctors may not yet prescribe cagrilintide. Participant will either get cagrilintide or placebo. Which treatment participant get is decided by chance. Participants are two times more likely to get cagrilintide than placebo. Like all medicines, the study medicine may have side effects. For each participant, the study will last for about 1 year and 6 months.
Key facts
- Study ID
- NCT07220759
- Run by
- Novo Nordisk A/S
- People needed
- 330
- Starts
- 2025-11-05
- Expected to finish
- 2027-06-30
- Last updated by the study team
- 2026-08-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Chambliss Clinical Trials, LLC — Montgomery, Alabama, United States
- Noble Clinical Research — Tucson, Arizona, United States
- Scripps Whittier Diabetes Inst — La Jolla, California, United States
- Headlands Research CTR Lincoln — Lincoln, California, United States
- Pacific Clinical Studies — Los Alamitos, California, United States
- Walgreens - Store 4442 — Kissimmee, Florida, United States
- Optimal Research Sites — Orange City, Florida, United States
- Center for Diab,Obes & Metab — Pembroke Pines, Florida, United States
- Palm Beach Research Center — West Palm Beach, Florida, United States
- East West Med Res Inst — Honolulu, Hawaii, United States
- MediSphere Medical RC — Evansville, Indiana, United States
- Walgreens - Store 3915 — Las Vegas, Nevada, United States
- Chear Center LLC — The Bronx, New York, United States
- Centricity Res New Bern Multispeciality — New Bern, North Carolina, United States
- Accellacare — Wilmington, North Carolina, United States
- Spartanburg Medical Research — Spartanburg, South Carolina, United States
- Holston Medical Group_Bristol — Bristol, Tennessee, United States
- Velocity Clinical Res-Dallas — Dallas, Texas, United States
- TPMG Clinical Research — Newport News, Virginia, United States
- National Clin Res Inc. — Richmond, Virginia, United States
- Buenos Aires Mácula — Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- CICEMO- Consultorio de Investigación Clínica EMO — Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- Centro Medico Dra. Laura Maffei e Investigacion Clínica Apli — Buenos Aires, Argentina
- OCT Research ULC (dba Okanagan Clinical Trials) — Kelowna, British Columbia, Canada
- Univ of Alabama_Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.